Petrillo v. Syntex Laboratories, Inc.

499 N.E.2d 952, 148 Ill. App. 3d 581, 102 Ill. Dec. 172, 1986 Ill. App. LEXIS 2952
CourtAppellate Court of Illinois
DecidedJune 26, 1986
Docket85-604
StatusPublished
Cited by192 cases

This text of 499 N.E.2d 952 (Petrillo v. Syntex Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Petrillo v. Syntex Laboratories, Inc., 499 N.E.2d 952, 148 Ill. App. 3d 581, 102 Ill. Dec. 172, 1986 Ill. App. LEXIS 2952 (Ill. Ct. App. 1986).

Opinion

PRESIDING JUSTICE LINN

delivered the opinion of the court:

Thomas E Tobin, a defense attorney for Syntex Laboratories, Inc. (Syntex), brings this appeal challenging the propriety of a trial court’s order finding him in contempt of court. The contempt citation was issued in connection with a product liability action instituted by several plaintiffs against Syntex. Tobin was found to be in contempt of court after he notified the trial court that he would not comply with the court’s order barring him from engaging in private, ex parte 1 conferences with the plaintiffs’ treating physicians.

On appeal, Tobin presents a multitude of arguments supporting his contention that the trial court’s contempt citation should be reversed and vacated. These arguments, while numerous, are essentially based on two general theories: (1) a plaintiff, by filing suit and placing his mental and physical condition at issue, waives his physician-patient privilege and therefore cannot object to defense counsel engaging in ex parte conferences with his treating physicians; and (2) prohibiting defense counsel from engaging in ex parte conferences with a plaintiff’s treating physician violates defense counsel’s first amendment freedom of speech rights.

We affirm the order of the trial court.

Background

During 1978 and 1979, Syntex produced and distributed two infant formulas named Neo-Mull-Soy and Cho-Free. In 1980, Michael Petrillo filed suit against Syntex alleging that he consumed Neo-MullSoy and was injured as a result. Soon thereafter, Petrillo’s action was consolidated, for discovery purposes, with 25 other plaintiffs alleging similar injuries resulting from their ingestion of Syntex’ formulas.

On May 18, 1984, while discovery in the consolidated action was taking place, Tobin informed the trial court that he had engaged in ex parte conferences with Dr. Lawrence Tomasi, one of Petrillo’s treating physicians. Upon hearing this, the attorney representing the plaintiffs moved the trial court to bar Tobin, or any agent of Syntex, from engaging in any future ex parte conferences with any of the plaintiffs’ (those 25 plaintiffs joined in the consolidated action) treating physicians. After a hearing on the matter, the trial court granted the motion finding that public policy bars such conferences.

On November 28, 1984, Tobin informed the trial court that he was going to engage in an ex parte conference with Dr. Green, a treating physician for one of the plaintiffs in the consolidated case. Although Tobin acknowledged that the ex parte conference would violate the trial court’s May 18, 1984, order, he nevertheless contended that the trial court erred in barring him from engaging in ex parte conferences with the plaintiffs’ treating physicians. Based on Tobin’s aforementioned conduct, the trial court held Tobin in direct contempt of court. On December 28,1984, the trial court fined Tobin the sum of $1.

Tobin now brings this appeal.

Opinion

Initially, we note that this is a case of first impression for an Illinois court of review. The Illinois Supreme Court has not yet addressed this issue nor is there any legislation directly on point. 2

As noted above, Tobin’s arguments urging reversal fall into two general categories: the waiver of the physician-patient privilege theory and the constitutional free speech theory.

Addressing first Tobin’s argument regarding the waiver issue, Tobin contends that ex parte conferences between defense counsel and a plaintiff’s treating physician should be permitted because: (1) no public policy exists which prohibits defense counsel from engaging in ex parte conferences with a plaintiff’s treating physician; (2) prohibiting defense counsel from engaging in ex parte conferences with treating physicians would force Tobin to obtain the opinions of treating physicians through depositions, a costly and inefficient means of gathering information; (3) prohibiting ex parte conferences between defense counsel and a plaintiff’s treating physician allows a plaintiff’s attorney to “neutralize” experts such as Dr. Tomasi; (4) barring Tobin from engaging in ex parte conferences with a plaintiff’s treating physician would allow “unscrupulous” plaintiffs to monitor the development of the defense’s case and thereby obtain “enough information to extort unjustified nuisance settlements”; (5) ex parte conferences are not barred by the ethical standards imposed upon attorneys; (6) a plaintiff has no proprietary right to any person’s testimony; (7) permitting ex parte discussions will help facilitate early evaluation and settlement of cases leading to a decrease in litigation costs and the conservation of judicial resources; (8) trial courts are empowered to take the necessary steps, such as the issuance of a protective order or the granting of a motion in limine, should any defense attorney abuse the ex parte conference; (9) ex parte conferences are not barred by the Supreme Court Rules or the applicable provisions of the Code of Civil Procedure; and (10) prohibiting ex parte conferences is tantamount to standing in the way of ascertaining the truth.

As a preliminary matter, Petrillo argues that our review should be limited to whether the trial court was correct in finding Tobin to be in violation of the court’s order and that we need not address, in answering this inquiry, the propriety of the trial court’s order itself.

In People ex rel. Scott v. Silverstein (1981), 87 Ill. 2d 167, 429 N.E.2d 483, the supreme court held that a contempt judgment including a fine or imprisonment “is a final and appealable judgment and presents to the court for review the propriety of the order claimed to have been violated.” (87 Ill. 2d 167, 174, 429 N.E.2d 483.) In the present case, Tobin was found in contempt and fined. Thus, the correctness of the trial court’s original order (which Tobin was found to have violated) is properly an issue before this court.

Before addressing the merits of each of Tobin’s respective arguments, we believe it critically important to note that Tobin has failed, in both his brief and during oral argument, to identify a single piece of information or evidence which he is able to obtain through an ex parte conference that he cannot obtain via the conventional methods of discovery outlined by Supreme Court Rule 201 (87 Ill. 2d R. 201 (oral depositions, depositions upon written questions, and discovery of documents)). In addition, a thorough review of case law from other jurisdictions reveals that in not one instance has a court found that ex parte conferences were necessary in order to permit defense counsel to obtain information that they were unable to obtain through the regular channels of discovery. Thus, it is undisputed that ex parte conferences yield no greater evidence, nor do they provide any additional information, than that which is already obtainable through the regular methods of discovery.

It is with this in mind that we now address the arguments raised by Tobin.

I

Tobin first contends that there is no public policy prohibiting ex parte conferences.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mertis, B. v. Oh Appeal of: Oh, M.D.
Supreme Court of Pennsylvania, 2024
Browning v. Advocate Health & Hospital Corp.
2023 IL App (1st) 221430 (Appellate Court of Illinois, 2023)
Meier v. Ryan
2023 IL App (1st) 211674 (Appellate Court of Illinois, 2023)
Nelson v. THC-Chicago, Inc.
2019 IL App (1st) 190968-U (Appellate Court of Illinois, 2019)
Kujawa v. Hopkins
2019 IL App (5th) 180568 (Appellate Court of Illinois, 2019)
Palm v. Holocker
2018 IL 123152 (Illinois Supreme Court, 2019)
People v. Beck
2017 IL App (4th) 160654 (Appellate Court of Illinois, 2018)
Caldwell v. Advocate Condell Medical Center
2017 IL App (2d) 160456 (Appellate Court of Illinois, 2017)
Emma Gayle Weaver, etc. v. Stephen C. Myers, M.D.
229 So. 3d 1118 (Supreme Court of Florida, 2017)
Leavitt v. Siems
2014 NV 54 (Nevada Supreme Court, 2014)
Fakes v. Eloy
2014 IL App (4th) 121100 (Appellate Court of Illinois, 2014)
Morisch v. United States
653 F.3d 522 (Seventh Circuit, 2011)
Aylward v. Settecase
948 N.E.2d 769 (Appellate Court of Illinois, 2011)
Birriel v. Odeh (In Re Odeh)
431 B.R. 807 (N.D. Illinois, 2010)
Kremers v. Coca-Cola Co.
712 F. Supp. 2d 759 (S.D. Illinois, 2010)
Valdovinos v. Tomita
914 N.E.2d 221 (Appellate Court of Illinois, 2009)
Sorensen v. Barbuto
2008 UT 8 (Utah Supreme Court, 2008)
Sorensen v. Barbuto
2006 UT App 340 (Court of Appeals of Utah, 2006)
Alsip v. Johnson City Medical Center
197 S.W.3d 722 (Tennessee Supreme Court, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
499 N.E.2d 952, 148 Ill. App. 3d 581, 102 Ill. Dec. 172, 1986 Ill. App. LEXIS 2952, Counsel Stack Legal Research, https://law.counselstack.com/opinion/petrillo-v-syntex-laboratories-inc-illappct-1986.